These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment. Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861 [TBL] [Abstract][Full Text] [Related]
4. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336 [TBL] [Abstract][Full Text] [Related]
5. Mammary epithelial cells treated concurrently with TGF-alpha and TGF-beta exhibit enhanced proliferation and death. Casey TM; Mulvey TM; Patnode TA; Dean A; Zakrzewska E; Plaut K Exp Biol Med (Maywood); 2007 Sep; 232(8):1027-40. PubMed ID: 17720949 [TBL] [Abstract][Full Text] [Related]
6. [Epithelial-mesenchymal transition in cancer progression]. Gos M; Miłoszewska J; Przybyszewska M Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467 [TBL] [Abstract][Full Text] [Related]
7. TGF-beta signaling in tumor suppression and cancer progression. Derynck R; Akhurst RJ; Balmain A Nat Genet; 2001 Oct; 29(2):117-29. PubMed ID: 11586292 [TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma. Yang F; Strand DW; Rowley DR Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. Tse JC; Kalluri R J Cell Biochem; 2007 Jul; 101(4):816-29. PubMed ID: 17243120 [TBL] [Abstract][Full Text] [Related]
11. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells. Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183 [TBL] [Abstract][Full Text] [Related]
12. Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart. Mercado-Pimentel ME; Runyan RB Cells Tissues Organs; 2007; 185(1-3):146-56. PubMed ID: 17587820 [TBL] [Abstract][Full Text] [Related]
13. Regulation of extracellular matrix remodeling following transforming growth factor-beta1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes. Wilkins-Port CE; Higgins PJ Cells Tissues Organs; 2007; 185(1-3):116-22. PubMed ID: 17587817 [TBL] [Abstract][Full Text] [Related]
14. TGF-beta during human colorectal carcinogenesis: the shift from epithelial to mesenchymal signaling. Matsuzaki K; Seki T; Okazaki K Inflammopharmacology; 2006 Dec; 14(5-6):198-203. PubMed ID: 17093904 [TBL] [Abstract][Full Text] [Related]
15. The effect of transforming growth factor beta on human neuroendocrine tumor BON cell proliferation and differentiation is mediated through somatostatin signaling. Leu FP; Nandi M; Niu C Mol Cancer Res; 2008 Jun; 6(6):1029-42. PubMed ID: 18567806 [TBL] [Abstract][Full Text] [Related]
16. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway. Yoo YA; Kang MH; Kim JS; Oh SC Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246 [TBL] [Abstract][Full Text] [Related]
17. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806 [TBL] [Abstract][Full Text] [Related]
18. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression. Gordon KJ; Dong M; Chislock EM; Fields TA; Blobe GC Carcinogenesis; 2008 Feb; 29(2):252-62. PubMed ID: 17999987 [TBL] [Abstract][Full Text] [Related]
19. Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism. Van Aarsen LA; Leone DR; Ho S; Dolinski BM; McCoon PE; LePage DJ; Kelly R; Heaney G; Rayhorn P; Reid C; Simon KJ; Horan GS; Tao N; Gardner HA; Skelly MM; Gown AM; Thomas GJ; Weinreb PH; Fawell SE; Violette SM Cancer Res; 2008 Jan; 68(2):561-70. PubMed ID: 18199553 [TBL] [Abstract][Full Text] [Related]
20. TGF-beta signaling: a tale of two responses. Rahimi RA; Leof EB J Cell Biochem; 2007 Oct; 102(3):593-608. PubMed ID: 17729308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]